Page last updated: 2024-09-05

erlotinib hydrochloride and Neurofibromatosis 1

erlotinib hydrochloride has been researched along with Neurofibromatosis 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, X; Chen, J; Cui, JD; Guo, XT; Li, Q	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Neurofibromatosis 1

Article	Year
Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1. Cancer medicine, 2018, Volume: 7, Issue:4 Topics: Adult; Aged; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Mutation; Neurofibromatosis 1; RNA Interference	2018

Article

Year

Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.

Cancer medicine, 2018, Volume: 7, Issue:4

Topics: Adult; Aged; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Mutation; Neurofibromatosis 1; RNA Interference

2018